Apoptosis And BCL-2
ABT-199/GDC-0199 is a small molecule drug in co-development by Abbvie and Genentech for the selective inhibition of BCL-2, a key regulator of cellular apoptosis. BCL-2, part of the larger BCL-2 family, is responsible for the sequestration of pro-apoptopic proteins along the mitochondrial membrane. Displacement of these proteins from BCL-2 in cancerous cells may prime these cells for apoptosis.
Видео Apoptosis And BCL-2 канала XVIVO Scientific Animation
Видео Apoptosis And BCL-2 канала XVIVO Scientific Animation
Показать
Комментарии отсутствуют
Информация о видео
26 октября 2020 г. 21:00:08
00:03:05
Другие видео канала
p53 Tumour Suppressor by wehi.tvApoptosis"What is Apoptosis?" The Apoptotic Pathways and the Caspase CascadeApoptosis Regulation by Genes | Bcl-2 FamilyIntroduction to Cancer Biology (Part 2): Loss of ApoptosisWhat is Necrosis vs What is Apoptosis?NIH UNLOCKING THE MYSTERIES OF EXTRACELLULAR RNA COMMUNICATIONApoptosis (Programmed Cell Death)QLS-101 MOACLL Whiteboard #3: Mechanisms of Action of Anti-Apoptotic BCL2 InhibitorsMechanism of Cytochrome C Release from MitochondriaApoptosis and venetoclaxScientists May Have Found a Way to Treat All Cancers... By Accident | SciShow NewsNEOPLASIA 3: TUMOR SUPPRESSOR GENES: Retinoblastoma Gene, Knudson's Two Hit Hypothesis.COBRA PLATFORM MOAApoptosis - Introduction, Morphologic Changes and MechanismVías de la ApoptosisApoptosis I Intrinsic Pathway I Programmed Cell DeathProgrammed Cell Death (apoptosis)Why We Haven't Cured Cancer